Therapeutic manipulation of apoptotic bodies formation to prevent respiratory infectious diseases
- Funded by National Health and Medical Research Council (NHMRC)
- Total publications:0 publications
Grant number: GA352305
Grant search
Key facts
Disease
COVID-19Start & end year
20242028Known Financial Commitments (USD)
$453,114.21Funder
National Health and Medical Research Council (NHMRC)Principal Investigator
N/A
Research Location
AustraliaLead Research Institution
La Trobe UniversityResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Disease pathogenesis
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Tuberculosis, COVID-19 and emerging respiratory infections are a continuing medical threat. At the same time, current effective anti-infective therapies are concerningly limited. This research program aims to develop novel treatments for infectious respiratory diseases by targeting the process in which infected host cells undergo fragmentation when they die. This will lead to more effective anti-infective treatments, thus relieving the rising burden of infectious diseases.